1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Saini KS, Loi S, de Azambuja E,
Metzger-Filho O, Saini ML, Ignatiadis M, Dancey JE and
Piccart-Gebhart MJ: Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK
pathways in the treatment of breast cancer. Cancer Treat Rev.
39:935–946. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Luga V, Zhang L, Viloria-Petit AM,
Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M and
Wrana JL: Exosomes mediate stromal mobilization of autocrine
Wnt-PCP signaling in breast cancer cell migration. Cell.
151:1542–1556. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
6
|
Dvinge H, Git A, Gräf S, Salmon-Divon M,
Curtis C, Sottoriva A, Zhao Y, Hirst M, Armisen J, Miska EA, et al:
The shaping and functional consequences of the microRNA landscape
in breast cancer. Nature. 497:378–382. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kakarougkas A, Ismail A, Katsuki Y, Freire
R, Shibata A and Jeggo PA: Co-operation of BRCA1 and POH1 relieves
the barriers posed by 53BP1 and RAP80 to resection. Nucleic Acids
Res. 41:10298–10311. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Stitzel ML, Durso R and Reese JC: The
proteasome regulates the UV-induced activation of the AP-1-like
transcription factor Gcn4. Genes Dev. 15:128–133. 2001. View Article : Google Scholar : PubMed/NCBI
|
9
|
Butler LR, Densham RM, Jia J, Garvin AJ,
Stone HR, Shah V, Weekes D, Festy F, Beesley J and Morris JR: The
proteasomal de-ubiquitinating enzyme POH1 promotes the
double-strand DNA break response. EMBO J. 31:3918–3934. 2012.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Byrne A, McLaren RP, Mason P, Chai L,
Dufault MR, Huang Y, Liang B, Gans JD, Zhang M, Carter K, et al:
Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest
and senescence. Exp Cell Res. 316:258–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang B, Ma A, Zhang L, Jin WL, Qian Y, Xu
G, Qiu B, Yang Z and Liu Y, Xia Q and Liu Y: POH1 deubiquitylates
and stabilizes E2F1 to promote tumour formation. Nat Commun.
6:878042015. View Article : Google Scholar
|
12
|
Gallery M, Blank JL, Lin Y, Gutierrez JA,
Pulido JC, Rappoli D, Badola S, Rolfe M and Macbeth KJ: The JAMM
motif of human deubiquitinase Poh1 is essential for cell viability.
Mol Cancer Ther. 6:262–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu H, Buus R, Clague MJ and Urbé S:
Regulation of ErbB2 receptor status by the proteasomal DUB POH1.
PLoS One. 4:e55442009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Nabhan JF and Ribeiro P: The 19 S
proteasomal subunit POH1 contributes to the regulation of c-Jun
ubiquitination, stability, and subcellular localization. J Biol
Chem. 281:16099–16107. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Schwarz T, Sohn C, Kaiser B, Jensen ED and
Mansky KC: The 19S proteasomal lid subunit POH1 enhances the
transcriptional activation by Mitf in osteoclasts. J Cell Biochem.
109:967–974. 2010.PubMed/NCBI
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Jiang J, Yu C, Chen M, Tian S and Sun C:
Over-expression of TRIM37 promotes cell migration and metastasis in
hepatocellular carcinoma by activating Wnt/β-catenin signaling.
Biochem Biophys Res Commun. 464:1120–1127. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Goswami CP and Nakshatri H: PROGgeneV2:
Enhancements on the existing database. BMC Cancer. 14:9702014.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Goswami CP and Nakshatri H: PROGgene: Gene
expression based survival analysis web application for multiple
cancers. J Clin Bioinforma. 3:222013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Wu SG, He ZY, Zhou J, Sun JY, Li FY, Lin
Q, Guo L and Lin HX: Serum levels of CEA and CA15-3 in different
molecular subtypes and prognostic value in Chinese breast cancer.
Breast. 23:88–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Lee JS, Park S, Park JM, Cho JH, Kim SI
and Park BW: Elevated levels of preoperative CA 15-3 and CEA serum
levels have independently poor prognostic significance in breast
cancer. Annals of oncology. 24:1225–1231. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Van Poznak C, Somerfield MR, Bast RC,
Cristofanilli M, Goetz MP, Gonzalez-Angulo AM, Hicks DG, Hill EG,
Liu MC, Lucas W, et al: Use of biomarkers to guide decisions on
systemic therapy for women with metastatic breast cancer: American
Society of Clinical Oncology Clinical Practice Guideline. J Clin
Oncol. 2015:2695–2704. 2015. View Article : Google Scholar
|
24
|
Morris JR: Attenuation of the ubiquitin
conjugate DNA damage signal by the proteasomal DUB POH1. Cell
Cycle. 11:4103–4104. 2012. View
Article : Google Scholar : PubMed/NCBI
|
25
|
Cooper EM, Cutcliffe C, Kristiansen TZ,
Pandey A, Pickart CM and Cohen RE: K63-specific deubiquitination by
two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal
Poh1. EMBO J. 28:621–631. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|